Remarkable Response to Third-Generation EGFR-TKI Plus Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring EGFR and ROS1 Co-Mutation: a Case Report
FRONTIERS IN ONCOLOGY（2024）
关键词
non-small cell lung cancer,EGFR,ROS1,tyrosine kinase inhibitors,co-mutation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要